Taft advised Advanced NanoTherapies on the fundraising.Advanced NanoTherapies Inc. (ANT) announced a $4 million Series A extension from a prominent undisclosed strategic medical device company. The investment…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
